publication . Article . 2017

Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers

Martin R. Weiser; Lily L. Lai; Karyn A. Goodman; Anna Ter Veer; Steven J. Nurkin; Marsha Reyngold; Al B. Benson; Joyce C. Niland; John M. Skibber; Joshua E. Meyer; ...
Open Access English
  • Published: 01 Oct 2017 Journal: Advances in Radiation Oncology (issn: 2452-1094, Copyright policy)
  • Publisher: Elsevier
Abstract Purpose Intensity modulated radiation therapy (IMRT) has been rapidly incorporated into clinical practice because of its technological advantages over 3-dimensional conformal radiation therapy (CRT). We characterized trends in IMRT utilization in trimodality treatment of locally advanced rectal cancer at National Comprehensive Cancer Network cancer centers between 2005 and 2011. Methods and materials Using the prospective National Comprehensive Cancer Network Colorectal Cancer Database, we determined treatment patterns for 976 patients with stage II-III rectal cancer who received pelvic radiation therapy at contributing centers between 2005 and 2011. Mu...
Medical Subject Headings: therapeutics
free text keywords: Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Gastrointestinal Cancer, Logistic regression, Resection, Medicine, business.industry, business, Cancer, medicine.disease, Intensity-modulated radiation therapy, Radiation therapy, medicine.medical_treatment, Oncology, medicine.medical_specialty, Clinical Practice, Colorectal cancer, Locally advanced, Internal medicine
27 references, page 1 of 2

Sauer, R., Becker, H., Hohenberger, W.. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351: 1731-1740 [PubMed]

Baglan, K.L., Frazier, R.C., Yan, D., Huang, R.R., Martinez, A.A., Robertson, J.M.. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2002; 52: 176-183 [PubMed]

Robertson, J.M., Lockman, D., Yan, D., Wallace, M.. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2008; 70: 413-418 [PubMed]

Tho, L.M., Glegg, M., Paterson, J.. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: Investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys. 2006; 66: 505-513 [OpenAIRE] [PubMed]

Arbea, L., Ramos, L.I., Martinez-Monge, R., Moreno, M., Aristu, J.. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): Dosimetric comparison and clinical implications. Radiat Oncol. 2010; 5: 17 [OpenAIRE] [PubMed]

Mok, H., Crane, C.H., Palmer, M.B.. Intensity modulated radiation therapy (IMRT): Differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiat Oncol. 2011; 6: 63 [OpenAIRE] [PubMed]

Jabbour, S.K., Patel, S., Herman, J.M.. Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits. Int J Surg Oncol. 2012; 891067: 2012

Parekh, A., Truong, M.T., Pashtan, I.. Acute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancer. Gastrointest Cancer Res. 2013; 6: 137-143 [OpenAIRE] [PubMed]

Yang, T.J., Oh, J.H., Son, C.H.. Predictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancer. Gastrointest Cancer Res. 2013; 6: 129-136 [OpenAIRE] [PubMed]

Gerard, J.P., Chapet, O., Nemoz, C.. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The lyon R96-02 randomized trial. J Clin Oncol. 2004; 22: 2404-2409 [PubMed]

Gerard, J.P., Azria, D., Gourgou-Bourgade, S.. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol. 2010; 28: 1638-1644 [PubMed]

Hartley, A., Ho, K.F., McConkey, C., Geh, J.I.. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: Analysis of phase II/III trials. Br J Radiol. 2005; 78: 934-938 [OpenAIRE] [PubMed]

Kachnic, L.A., Winter, K.A., Myerson, R.J.. RTOG 0529: A phase II evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2013; 86: 27-33 [OpenAIRE] [PubMed]

Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R.. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987; 40: 373-383 [OpenAIRE] [PubMed]

Guadagnolo, B.A., Liu, C.C., Cormier, J.N., Du, X.L.. Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: Socioeconomic disparity and geographic variation in a large population-based cohort. Cancer. 2010; 116: 3505-3512 [PubMed]

27 references, page 1 of 2
Any information missing or wrong?Report an Issue